medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2023-35-12-18medalphabet-3491Research ArticleСтатьиОстрый коронарный синдром у пациентов с онкологическими заболеваниямиAcute coronary syndrome in patients with oncological diseaseshttps://orcid.org/0000-0002-2619-1592БлизнюкС. А.BliznyukS. А.

Близнюк Светлана Александровна, к.м.н., зав. кардиологическим отделением, н.с. 

 

Bliznyuk Svetlana A., PhD Med, head of Cardiology Dept, researche

Moscow

https://orcid.org/0000-0002-8633-7012КомароваА. Г.KomarovaA. G.

Комарова Анна Григорьевна, к.м.н., зам. гл. врача по медицинской части по региональному сосудистому центру, в.н.с., врач-кардиолог

Komarova Anna G., PhD Med, deputy chief physician for medical affairs at Regional Vascular Centre, leading researcher, cardiologist

Moscow

https://orcid.org/0000-0002-0912-6342ЛибовИ. А.LibovI. A.

Либов Игорь Айзикович, к.м.н., с.н.с. 

Libov Igor A., PhD Med, senior researcher

Moscow

https://orcid.org/0000-0003-2701-3525ЛяховаН. Л.LyakhovaN. L.

Ляхова Наталия Леонидовна, к.м.н., зав. кардиологическим отделением, н.с., врач-кардиолог 

Lyakhova Natalia L., PhD Med, head of Cardiology Dept, researcher, cardiologist

Moscow

https://orcid.org/0000-0001-8614-8150АлексеевВ. Г.AlekseevV. G.

Алексеев Владимир Григорьевич, д.м.н., проф., врач-терапевт

Alekseev Vladimir G., DM Sci (habil.), professor, general practitioner

Moscow

ГБУЗ г. Москвы «Городская клиническая больница имени С. П. Боткина Департамента здравоохранения Москвы»РоссияCity Clinical Hospital n.a. S. P. BotkinRussian Federation202318012024035Кардиология. Неотложная медицина (4)1218Copyright © Близнюк С.А., Комарова А.Г., Либов И.А., Ляхова Н.Л., Алексеев В.Г., 20242024Близнюк С.А., Комарова А.Г., Либов И.А., Ляхова Н.Л., Алексеев В.Г.Bliznyuk S.А., Komarova A.G., Libov I.A., Lyakhova N.L., Alekseev V.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/3491

Цель данной работы – повысить настороженность врачей, курирующих онкологических больных, в отношении высокого риска развития у них острого коронарного синдрома (ОКС) и понимание особенностей патогенетических механизмов его развития. Противоопухолевая терапия должна быть персонифицирована и согласована междисциплинарной командой с оценкой ее влияния на риск развития ОКС, особенно у больных высокого сердечно-сосудистого риска. С учетом ограниченного количества исследований, принципы ведения онкологических больных с ОКС должны быть основаны на оценке ишемических и геморрагических рисков.

The purpose of this work is to increase the alertness of doctors treating cancer patients due to the high risk of developing acute coronary syndrome (ACS) and understanding the pathogenetic mechanisms of the development of ACS. Antitumor therapy should be personalized and agreed upon by an interdisciplinary team with an assessment of the impact on the risk of developing ACS, especially in patients with high cardiovascular risk. Given the limited number of studies, principles for the management of cancer patients with ACS should be based on an assessment of ischemic and hemorrhagic risks.

острый коронарный синдроминфаркт миокардараконкологические заболеванияхимиотерапияacute coronary syndromemyocardial infarctioncanceroncological diseaseschemotherapyReferencesNavi B. B., Reiner A. S., Kamel H., Iadecola C., Okin P. M., Tagawa S. T., Panageas K. S., DeAngelis L. M. Arterial thromboembolic events preceding the diagnosis of cancer in old er persons. Blood. 2019; 133 (8): 781–789. https://doi.org/10.1182/blood2018–06–860874Navi B. B., Reiner A. S., Kamel H., Iadecola C., Okin P. M., Tagawa S. T., Panageas K. S., DeAngelis L. M. Arterial thromboembolic events preceding the diagnosis of cancer in old er persons. Blood. 2019; 133 (8): 781–789. https://doi.org/10.1182/blood2018–06–860874Rohrmann S., Witassek F., Erne P., Rickli H., Radovanovic D. Treatment of patients with myocardial infarction depends on history of cancer. Eur Heart J Acute Cardiovasc Care. 2018; 7 (7): 639–645. https://doi.org/10.1177/2048872617729636Rohrmann S., Witassek F., Erne P., Rickli H., Radovanovic D. Treatment of patients with myocardial infarction depends on history of cancer. Eur Heart J Acute Cardiovasc Care. 2018; 7 (7): 639–645. https://doi.org/10.1177/2048872617729636Wang F., Gulati R., Lennon R. J., Lewis B. R., Park J., Sandhu G. S., Wright R. S., Lerman A., Herrmann J. Cancer History Portends Worse Acute and Longterm Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Intervention for Acute STSegment Elevation Myocardial Infarction. Mayo Clin Proc. 2016; 91 (12): 1680–1692. https://doi.org/10.1016/j.mayocp.2016.06.029Wang F., Gulati R., Lennon R. J., Lewis B. R., Park J., Sandhu G. S., Wright R. S., Lerman A., Herrmann J. Cancer History Portends Worse Acute and Longterm Noncardiac (but Not Cardiac) Mortality After Primary Percutaneous Coronary Intervention for Acute STSegment Elevation Myocardial Infarction. Mayo Clin Proc. 2016; 91 (12): 1680–1692. https://doi.org/10.1016/j.mayocp.2016.06.029Gevaert S. A., Halvorsen S., Sinnaeve P. R., Sambola A., Gulati G., Lancellotti P., Van Der Meer P., Lyon A. R., Farmakis D., Lee G., Boriani G., Wechalekar A., Okines A., As teggiano R. Evaluation and management of cancer patients presenting with acute cardiovascular disease: A Consensus Document of the Acute Cardio Vascular Care (ACVC) association and the ESC council of CardioOncologyPart 1: Acute coronary syndromes and acute pericardial diseases. Eur Heart J Acute Cardiovasc Care. 2021; 10 (8): 947–959. PMID: 34453829. https://doi.org/10.1093/ehjacc/zuab056Gevaert S. A., Halvorsen S., Sinnaeve P. R., Sambola A., Gulati G., Lancellotti P., Van Der Meer P., Lyon A. R., Farmakis D., Lee G., Boriani G., Wechalekar A., Okines A., As teggiano R. Evaluation and management of cancer patients presenting with acute cardiovascular disease: A Consensus Document of the Acute Cardio Vascular Care (ACVC) association and the ESC council of CardioOncologyPart 1: Acute coronary syndromes and acute pericardial diseases. Eur Heart J Acute Cardiovasc Care. 2021; 10 (8): 947–959. PMID: 34453829. https://doi.org/10.1093/ehjacc/zuab056Iannaccone M., D’Ascenzo F., Vadalà P., Wilton S. B., Noussan P., Colombo F., Rapo seiras Roubín S., Abu Assi E., GonzálezJuanatey J.R., Simao Henriques J. P., Saucedo J., Kikkert W. J., NuñezGil I., ArizaSole A., Song X. T., Alexopoulos D., Liebetrau C., Kawaji T., Moretti C., Garbo R., Huczek Z., Nie S. P., Fujii T, Correia L. C., Kawashiri M. A., García Acuña J. M., Southern D., Alfonso E., Terol B., Garay A., Zhang D., Chen Y., Xanthopou lou I., Osman N., Möllmann H., Shiomi H., Giordana F., Kowara M., Filipiak K., Wang X., Yan Y., Fan J. Y., Ikari Y., Nakahashi T., Sakata K., Gaita F., Yamagishi M., Kalpak O., Kedev S. Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy. Eur Heart J Acute Cardiovasc Care. 2018; 7 (7): 631–638. https://doi.org/10.1177/2048872617706501Iannaccone M., D’Ascenzo F., Vadalà P., Wilton S. B., Noussan P., Colombo F., Rapo seiras Roubín S., Abu Assi E., GonzálezJuanatey J.R., Simao Henriques J. P., Saucedo J., Kikkert W. J., NuñezGil I., ArizaSole A., Song X. T., Alexopoulos D., Liebetrau C., Kawaji T., Moretti C., Garbo R., Huczek Z., Nie S. P., Fujii T, Correia L. C., Kawashiri M. A., García Acuña J. M., Southern D., Alfonso E., Terol B., Garay A., Zhang D., Chen Y., Xanthopou lou I., Osman N., Möllmann H., Shiomi H., Giordana F., Kowara M., Filipiak K., Wang X., Yan Y., Fan J. Y., Ikari Y., Nakahashi T., Sakata K., Gaita F., Yamagishi M., Kalpak O., Kedev S. Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy. Eur Heart J Acute Cardiovasc Care. 2018; 7 (7): 631–638. https://doi.org/10.1177/2048872617706501Edmondson D., von Känel R. Posttraumatic stress disorder and cardiovascular disease. Lancet Psychiatry. 2017; 4 (4): 320–329. https://doi.org/10.1016/s2215–0366(16)30377–7Edmondson D., von Känel R. Posttraumatic stress disorder and cardiovascular disease. Lancet Psychiatry. 2017; 4 (4): 320–329. https://doi.org/10.1016/s2215–0366(16)30377–7ArizaSolé A., Guerrero C., Formiga F., Aboal J., AbuAssi E., Marín F., Bueno H., Alegre O., LópezPalop R., Vidán M. T., MartínezSellés M., DíezVillanueva P., Vilardell P., Sionis A., VivesBorrás M., Sanchís J., Bañeras J., Rafecas A., Llibre C., López J., GonzálezSal vado V., Cequier À.; LONGEVOSCA Registry Investigators. Global Geriatric Assessment and InHospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVOSCA Registry. Thromb Haemost. 2018; 118 (3): 581–590. https://doi.org/10.1055/s0038–1623532ArizaSolé A., Guerrero C., Formiga F., Aboal J., AbuAssi E., Marín F., Bueno H., Alegre O., LópezPalop R., Vidán M. T., MartínezSellés M., DíezVillanueva P., Vilardell P., Sionis A., VivesBorrás M., Sanchís J., Bañeras J., Rafecas A., Llibre C., López J., GonzálezSal vado V., Cequier À.; LONGEVOSCA Registry Investigators. Global Geriatric Assessment and InHospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVOSCA Registry. Thromb Haemost. 2018; 118 (3): 581–590. https://doi.org/10.1055/s0038–1623532ManzanoFernández S., SánchezMartínez M., FloresBlanco P.J., LópezCuenca Á., GómezMolina M., PastorPérez F.J., SánchezGalian M.J., CambroneroSanchez F., Guerrero Pérez E., GarcíaNarbón A., de Las HerasGómez I., Valdés M. Comparison of the Global Registry of Acute Coronary Events Risk Score Versus the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse outcomes With Early Implementation of the ACC/AHA Guidelines Risk Score to Predict InHospital Mortality and Major Bleeding in Acute Coronary Syndromes. Am J Cardiol. 2016; 117 (7): 1047–54. https://doi.org/10.1016/j.amjcard.2015.12.048ManzanoFernández S., SánchezMartínez M., FloresBlanco P.J., LópezCuenca Á., GómezMolina M., PastorPérez F.J., SánchezGalian M.J., CambroneroSanchez F., Guerrero Pérez E., GarcíaNarbón A., de Las HerasGómez I., Valdés M. Comparison of the Global Registry of Acute Coronary Events Risk Score Versus the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse outcomes With Early Implementation of the ACC/AHA Guidelines Risk Score to Predict InHospital Mortality and Major Bleeding in Acute Coronary Syndromes. Am J Cardiol. 2016; 117 (7): 1047–54. https://doi.org/10.1016/j.amjcard.2015.12.048Guerrero C., Garay A., ArizaSolé A., Formiga F., RaposeirasRoubín S., AbuAssi E., D’As cenzo F., Kinnaird T., ManzanoFernández S., Alegre O., SánchezSalado J.C., Lorente V., Templin C., Velicki L., Xanthopoulou I., Cerrato E., Rognoni A., Boccuzzi G., Omedè P., Montabone A., Taha S., Durante A., Gili S., Magnani G., Conrotto F., Bertaina M., Autelli M., Grosso A., Blanco P. F., Quadri G., Varbella F., Tomassini F., Queija B. C., Paz R. C., Fernández M. C., Pousa I. M., Gallo D., Morbiducci U., DominguezRodriguez A., Valdés M., Alexopoulos D., IñiguezRomo A., Gaita F., Cequier Á. Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry. Thromb Res. 2018; 167: 142–148. https://doi.org/10.1016/j.thromres.2018.05.024Guerrero C., Garay A., ArizaSolé A., Formiga F., RaposeirasRoubín S., AbuAssi E., D’As cenzo F., Kinnaird T., ManzanoFernández S., Alegre O., SánchezSalado J.C., Lorente V., Templin C., Velicki L., Xanthopoulou I., Cerrato E., Rognoni A., Boccuzzi G., Omedè P., Montabone A., Taha S., Durante A., Gili S., Magnani G., Conrotto F., Bertaina M., Autelli M., Grosso A., Blanco P. F., Quadri G., Varbella F., Tomassini F., Queija B. C., Paz R. C., Fernández M. C., Pousa I. M., Gallo D., Morbiducci U., DominguezRodriguez A., Valdés M., Alexopoulos D., IñiguezRomo A., Gaita F., Cequier Á. Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry. Thromb Res. 2018; 167: 142–148. https://doi.org/10.1016/j.thromres.2018.05.024Lancellotti P., Marechal P., Donis N., Oury C. Inflammation, cardiovascular disease, and cancer: a common link with farreaching implications. Eur Heart J. 2019; 40 (48): 3910–3912. https://doi.org/10.1093/eurheartj/ehz645Lancellotti P., Marechal P., Donis N., Oury C. Inflammation, cardiovascular disease, and cancer: a common link with farreaching implications. Eur Heart J. 2019; 40 (48): 3910–3912. https://doi.org/10.1093/eurheartj/ehz645Das D., Asher A., Ghosh A. K. Cancer and Coronary Artery Disease: Common Associa tions, Diagnosis and Management Challenges. Curr Treat Options Oncol. 2019; 20 (6): 46. https://doi.org/10.1007/s11864–019–0644–3Das D., Asher A., Ghosh A. K. Cancer and Coronary Artery Disease: Common Associa tions, Diagnosis and Management Challenges. Curr Treat Options Oncol. 2019; 20 (6): 46. https://doi.org/10.1007/s11864–019–0644–3Sung H., Ferlay J., Siegel R. L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71 (3): 209–249. https://doi.org/10.3322/caac.21660Sung H., Ferlay J., Siegel R. L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71 (3): 209–249. https://doi.org/10.3322/caac.21660Oren O., Herrmann J. Arterial events in cancer patientsthe case of acute coronary throm bosis. J Thorac Dis. 2018; 10 (Suppl 35): S4367–S4385. https://doi.org/10.21037/jtd.2018.12.79Oren O., Herrmann J. Arterial events in cancer patientsthe case of acute coronary throm bosis. J Thorac Dis. 2018; 10 (Suppl 35): S4367–S4385. https://doi.org/10.21037/jtd.2018.12.79Gong I. Y., Yan A. T., Ko D. T., Earle C. C., Cheung W. Y., Peacock S., Hall M., Gale C. P., Chan K. K.W. Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013. Cancer. 2018; 124 (6): 1269–1278. https://doi.org/10.1002/cncr.31174Gong I. Y., Yan A. T., Ko D. T., Earle C. C., Cheung W. Y., Peacock S., Hall M., Gale C. P., Chan K. K.W. Temporal changes in treatments and outcomes after acute myocardial infarction among cancer survivors and patients without cancer, 1995 to 2013. Cancer. 2018; 124 (6): 1269–1278. https://doi.org/10.1002/cncr.31174Balanescu D. V., Donisan T., Deswal A., Palaskas N., Song J., LopezMattei J., Kim P. Y., Durand J. B., Doundoua D., Marmagkiolis K., Iliescu C. Acute myocardial infarction in a highrisk cancer population: Outcomes following conservative versus invasive management. Int J Cardiol. 2020; 313: 1–8. https://doi.org/0.1016/j.ijcard.2020.04.050Balanescu D. V., Donisan T., Deswal A., Palaskas N., Song J., LopezMattei J., Kim P. Y., Durand J. B., Doundoua D., Marmagkiolis K., Iliescu C. Acute myocardial infarction in a highrisk cancer population: Outcomes following conservative versus invasive management. Int J Cardiol. 2020; 313: 1–8. https://doi.org/0.1016/j.ijcard.2020.04.050Navi B. B., Reiner A. S., Kamel H., Iadecola C., Okin P. M., Elkind M. S.V, Panageas K. S., DeAngelis L. M. Risk of Arterial Thromboembolism in Patients with Cancer. J Am Coll Cardiol. 2017; 70 (8): 926–938. https://doi.org/0.1016/j.jacc.2017.06.047Navi B. B., Reiner A. S., Kamel H., Iadecola C., Okin P. M., Elkind M. S.V, Panageas K. S., DeAngelis L. M. Risk of Arterial Thromboembolism in Patients with Cancer. J Am Coll Cardiol. 2017; 70 (8): 926–938. https://doi.org/0.1016/j.jacc.2017.06.047Park J. Y., Guo W., AlHijji M., El Sabbagh A., Begna K. H., Habermann T. M., Witzig T. E., Lewis B. R., Lerman A., Herrmann J. Acute coronary syndromes in patients with active hematologic malignancies – Incidence, management, and outcomes. Int J Cardiol. 2019; 275: 6–12. https://doi.org/10.1016/j.ijcard.2018.10.008Park J. Y., Guo W., AlHijji M., El Sabbagh A., Begna K. H., Habermann T. M., Witzig T. E., Lewis B. R., Lerman A., Herrmann J. Acute coronary syndromes in patients with active hematologic malignancies – Incidence, management, and outcomes. Int J Cardiol. 2019; 275: 6–12. https://doi.org/10.1016/j.ijcard.2018.10.008Koene R. J., Prizment A. E., Blaes A., Konety S. H. Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation. 2016; 133 (11): 1104–14. https://doi.org/10.1161/circulationaha.115.020406Koene R. J., Prizment A. E., Blaes A., Konety S. H. Shared Risk Factors in Cardiovascular Disease and Cancer. Circulation. 2016; 133 (11): 1104–14. https://doi.org/10.1161/circulationaha.115.020406Lenneman C. G., Sawyer D. B. CardioOncology: An Update on Cardiotoxicity of CancerRelated Treatment. Circ Res. 2016; 118 (6): 1008–20. https://doi.org/10.1161/circresaha.115.303633Lenneman C. G., Sawyer D. B. CardioOncology: An Update on Cardiotoxicity of CancerRelated Treatment. Circ Res. 2016; 118 (6): 1008–20. https://doi.org/10.1161/circresaha.115.303633Caine G. J., Stonelake P. S., Lip G. Y., Kehoe S. T. The hypercoagulable state of malig nancy: pathogenesis and current debate. Neoplasia. 2002; 4 (6): ca465–73. https://doi.org/10.1038/sj.neo.7900263Caine G. J., Stonelake P. S., Lip G. Y., Kehoe S. T. The hypercoagulable state of malig nancy: pathogenesis and current debate. Neoplasia. 2002; 4 (6): ca465–73. https://doi.org/10.1038/sj.neo.7900263Canale M. L., Bisceglia I., Lestuzzi C., Parrini I.; ANMCO CardioOncology Task Force. Arterial Thrombosis in Cancer: Spotlight on the Neglected Vessels. Anticancer Res. 2019; 39 (9): 4619–4625. https://doi.org/10.21873/anticanres.13642Canale M. L., Bisceglia I., Lestuzzi C., Parrini I.; ANMCO CardioOncology Task Force. Arterial Thrombosis in Cancer: Spotlight on the Neglected Vessels. Anticancer Res. 2019; 39 (9): 4619–4625. https://doi.org/10.21873/anticanres.13642Libby P., Kobold S. Inflammation: a common contributor to cancer, aging, and cardio vascular diseasesexpanding the concept of cardiooncology. Cardiovasc Res. 2019 Apr 15; 115(5): 824–829. https://doi.org/10.1093/cvr/cvz058Libby P., Kobold S. Inflammation: a common contributor to cancer, aging, and cardio vascular diseasesexpanding the concept of cardiooncology. Cardiovasc Res. 2019 Apr 15; 115(5): 824–829. https://doi.org/10.1093/cvr/cvz058Rak J., Milsom C., May L., Klement P., Yu J. Tissue factor in cancer and angiogenesis: The molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost. 2006; 32 (1): 54–70. https://doi.org/10.1055/s2006–933341Rak J., Milsom C., May L., Klement P., Yu J. Tissue factor in cancer and angiogenesis: The molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy. Semin Thromb Hemost. 2006; 32 (1): 54–70. https://doi.org/10.1055/s2006–933341Yeh E. T.H., Chang H. M. Cancer and Clot: Between a Rock and a Hard Place. J Am Coll Cardiol. 2017; 70 (8): 939–941. https://doi.org/10.1016/j.jacc.2017.07.719Yeh E. T.H., Chang H. M. Cancer and Clot: Between a Rock and a Hard Place. J Am Coll Cardiol. 2017; 70 (8): 939–941. https://doi.org/10.1016/j.jacc.2017.07.719BallesterosOrtega D., MartínezGonzález O., GómezCasero R.B., QuintanaDíaz M., de MiguelBalsa E., MartínParra C., LópezMatamala B., ChanaGarcía M., AlonsoFernán dez M.Á., MansoÁlvarez M. Characteristics of patients with myocardial infarction with nonobstructive coronary arteries (MINOCA) from the ARIAMSEMICYUC registry: development of a score for predicting MINOCA. Vasc Health Risk Manag. 2019; 15: 57–67. https://doi.org/10.2147/vhrm.S185082BallesterosOrtega D., MartínezGonzález O., GómezCasero R.B., QuintanaDíaz M., de MiguelBalsa E., MartínParra C., LópezMatamala B., ChanaGarcía M., AlonsoFernán dez M.Á., MansoÁlvarez M. Characteristics of patients with myocardial infarction with nonobstructive coronary arteries (MINOCA) from the ARIAMSEMICYUC registry: development of a score for predicting MINOCA. Vasc Health Risk Manag. 2019; 15: 57–67. https://doi.org/10.2147/vhrm.S185082Whitlock M. C., Yeboah J., Burke G. L., Chen H., Klepin H. D., Hundley W. G. Cancer and Its Association with the Development of Coronary Artery Calcification: An Assessment from the MultiEthnic Study of Atherosclerosis. J Am Heart Assoc. 2015; 4 (11): e002533. https://doi.org/10.1161/jaha.115.002533Whitlock M. C., Yeboah J., Burke G. L., Chen H., Klepin H. D., Hundley W. G. Cancer and Its Association with the Development of Coronary Artery Calcification: An Assessment from the MultiEthnic Study of Atherosclerosis. J Am Heart Assoc. 2015; 4 (11): e002533. https://doi.org/10.1161/jaha.115.002533Giza D. E., Iliescu G., Hassan S., Marmagkiolis K., Iliescu C. Cancer as a Risk Factor for Cardiovascular Disease. Curr Oncol Rep. 2017; 19 (6): 39. https://doi.org/10.1007/s11912–017–0601xGiza D. E., Iliescu G., Hassan S., Marmagkiolis K., Iliescu C. Cancer as a Risk Factor for Cardiovascular Disease. Curr Oncol Rep. 2017; 19 (6): 39. https://doi.org/10.1007/s11912–017–0601xBanasiak W., Zymliński R., Undas A. Optimal management of cancer patients with acute coronary syndrome. Pol Arch Intern Med. 2018; 128 (4): 244–253. https://doi.org/10.20452/pamw.4254Banasiak W., Zymliński R., Undas A. Optimal management of cancer patients with acute coronary syndrome. Pol Arch Intern Med. 2018; 128 (4): 244–253. https://doi.org/10.20452/pamw.4254Connolly G. C., Phipps R. P., Francis C. W. Platelets and cancerassociated thrombosis. Semin Oncol. 2014; 41 (3): 302–10. https://doi.org/10.1053/j.seminoncol.2014.04.009Connolly G. C., Phipps R. P., Francis C. W. Platelets and cancerassociated thrombosis. Semin Oncol. 2014; 41 (3): 302–10. https://doi.org/10.1053/j.seminoncol.2014.04.009van Es N., Sturk A., Middeldorp S., Nieuwland R. Effects of Cancer on Platelets. Seminars in Oncology. 2014; 41: 311–318van Es N., Sturk A., Middeldorp S., Nieuwland R. Effects of Cancer on Platelets. Seminars in Oncology. 2014; 41: 311–318Iliescu C., Balanescu D. V., Donisan T., Giza D. E., Muñoz Gonzalez E. D., Cilingiroglu M., Song J., Mukerji S. S., LopezMattei J.C., Kim P. Y., Palaskas N., Mouhayar E. N., Durand J. B., Marmagkiolis K. Safety of Diagnostic and Therapeutic Cardiac Catheterization in Cancer Patients with Acute Coronary Syndrome and Chronic Thrombocytopenia. Am J Cardiol. 2018; 122 (9): 1465–1470. DOI: 10.1053/10.1016/j.amjcard.2018.07.033.Iliescu C., Balanescu D. V., Donisan T., Giza D. E., Muñoz Gonzalez E. D., Cilingiroglu M., Song J., Mukerji S. S., LopezMattei J.C., Kim P. Y., Palaskas N., Mouhayar E. N., Durand J. B., Marmagkiolis K. Safety of Diagnostic and Therapeutic Cardiac Catheterization in Cancer Patients with Acute Coronary Syndrome and Chronic Thrombocytopenia. Am J Cardiol. 2018; 122 (9): 1465–1470. DOI: 10.1053/10.1016/j.amjcard.2018.07.033.Aronson D., Brenner B. Arterial thrombosis and cancer. Thromb Res. 2018; 164 Suppl 1: S 23–S 28. DOI: 10.1016/j.thromres.2018.01.003.Aronson D., Brenner B. Arterial thrombosis and cancer. Thromb Res. 2018; 164 Suppl 1: S 23–S 28. DOI: 10.1016/j.thromres.2018.01.003.Jaiswal S., Natarajan P., Silver A. J., Gibson C. J., Bick A. G., Shvartz E, McConkey M., Gupta N., Gabriel S., Ardissino D, Baber U, Mehran R, Fuster V, Danesh J, Frossard P, Saleheen D, Melander O, Sukhova GK, Neuberg D, Libby P, Kathiresan S, Ebert BL. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med. 2017 Jul 13; 377 (2): 111–121. DOI: 10.1056/nejmoa1701719.Jaiswal S., Natarajan P., Silver A. J., Gibson C. J., Bick A. G., Shvartz E, McConkey M., Gupta N., Gabriel S., Ardissino D, Baber U, Mehran R, Fuster V, Danesh J, Frossard P, Saleheen D, Melander O, Sukhova GK, Neuberg D, Libby P, Kathiresan S, Ebert BL. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease. N Engl J Med. 2017 Jul 13; 377 (2): 111–121. DOI: 10.1056/nejmoa1701719.Montone R. A., Niccoli G., Fracassi F., Russo M., Gurgoglione F., Cammà G., Lanza G. A., Crea F. Patients with acute myocardial infarction and nonobstructive coronary arteries: Safety and prognostic relevance of invasive coronary provocative tests. European Heart Journal. 2018; 39 (2); 91–98. https://doi.org/10.1093/eurheartj/ehx667Montone R. A., Niccoli G., Fracassi F., Russo M., Gurgoglione F., Cammà G., Lanza G. A., Crea F. Patients with acute myocardial infarction and nonobstructive coronary arteries: Safety and prognostic relevance of invasive coronary provocative tests. European Heart Journal. 2018; 39 (2); 91–98. https://doi.org/10.1093/eurheartj/ehx667Tsibiribi P., BuiXuan C., BuiXuan B., LombardBohas C., Duperret S., Belkhiria M., Tabib A., Maujean G., Descotes J., Timour Q. Cardiac lesions induced by 5fluorouracil in the rabbit. Hum Exp Toxicol. 2006; 25 (6): 305–9. https://doi.org/10.1191/0960327106ht628oaTsibiribi P., BuiXuan C., BuiXuan B., LombardBohas C., Duperret S., Belkhiria M., Tabib A., Maujean G., Descotes J., Timour Q. Cardiac lesions induced by 5fluorouracil in the rabbit. Hum Exp Toxicol. 2006; 25 (6): 305–9. https://doi.org/10.1191/0960327106ht628oaKumar S., Gupta R. K., Samal N. 5fluorouracil induced cardiotoxicity in albino rats. Mater Med Pol. 1995; 27 (2): 63–6.Kumar S., Gupta R. K., Samal N. 5fluorouracil induced cardiotoxicity in albino rats. Mater Med Pol. 1995; 27 (2): 63–6.Herrmann J., Yang E. H., Iliescu C. A., Cilingiroglu M., Charitakis K., Hakeem A., Toutouzas K., Leesar M. A., Grines C. L., Marmagkiolis K. Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue. Circulation. 2016; 133 (13): 1272–89. https://doi.org/10.1161/circulationaha.115.018347Herrmann J., Yang E. H., Iliescu C. A., Cilingiroglu M., Charitakis K., Hakeem A., Toutouzas K., Leesar M. A., Grines C. L., Marmagkiolis K. Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue. Circulation. 2016; 133 (13): 1272–89. https://doi.org/10.1161/circulationaha.115.018347Herrmann J., Yang E. H., Iliescu C. A., Cilingiroglu M., Charitakis K., Hakeem A., Toutouzas K., Leesar M. A., Grines C. L., Marmagkiolis K. Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue. Circulation; 133 (13): 1272–89. DOI: 10.1161/ circulationaha.115.018347.Herrmann J., Yang E. H., Iliescu C. A., Cilingiroglu M., Charitakis K., Hakeem A., Toutouzas K., Leesar M. A., Grines C. L., Marmagkiolis K. Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue. Circulation; 133 (13): 1272–89. DOI: 10.1161/ circulationaha.115.018347.Sasaki W., Wada H., Sakakura K., Matsuda J., Ibe T., Hayashi T., Ueba H., Momomura S. I., Fujita H. Coronary vasospasm induced by cisplatin for seminoma. Clin Case Rep. 2019; 8 (1): 190–193. https://doi.org/10.1002/ccr3.2601Sasaki W., Wada H., Sakakura K., Matsuda J., Ibe T., Hayashi T., Ueba H., Momomura S. I., Fujita H. Coronary vasospasm induced by cisplatin for seminoma. Clin Case Rep. 2019; 8 (1): 190–193. https://doi.org/10.1002/ccr3.2601Hanchate L. P., Sharma S. R., Madyalkar S. Cisplatin Induced Acute Myocardial Infarction and Dyslipidemia. J Clin Diagn Res. 2017; 11 (6): OD 05–OD 07. https://doi.org/10.7860/jcdr/2017/25546.10025Hanchate L. P., Sharma S. R., Madyalkar S. Cisplatin Induced Acute Myocardial Infarction and Dyslipidemia. J Clin Diagn Res. 2017; 11 (6): OD 05–OD 07. https://doi.org/10.7860/jcdr/2017/25546.10025Hassan S. A., Palaskas N., Kim P., Iliescu C., LopezMattei J., Mouhayar E., Mougdil R., Thompson K., Banchs J., Yusuf S. W. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis. Curr Atheroscler Rep. 2018; 20 (2): 10. https://doi.org/10.1007/ s11883–018–0702–5Hassan S. A., Palaskas N., Kim P., Iliescu C., LopezMattei J., Mouhayar E., Mougdil R., Thompson K., Banchs J., Yusuf S. W. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis. Curr Atheroscler Rep. 2018; 20 (2): 10. https://doi.org/10.1007/ s11883–018–0702–5Yusuf S. W., Daraban N., Abbasi N., Lei X., Durand J. B., Daher I. N. Treatment and out comes of acute coronary syndrome in the cancer population. Clin Cardiol. 2012; 35 (7): 443–50. https://doi.org/10.1002/clc.22007Yusuf S. W., Daraban N., Abbasi N., Lei X., Durand J. B., Daher I. N. Treatment and out comes of acute coronary syndrome in the cancer population. Clin Cardiol. 2012; 35 (7): 443–50. https://doi.org/10.1002/clc.22007Radmilovic J., Di Vilio A., D’Andrea A., Pastore F., Forni A., Desiderio A., Ragni M., Quar anta G., Cimmino G., Russo V., Scherillo M., Golino P. The Pharmacological Approach to Oncologic Patients with Acute Coronary Syndrome. J Clin Med. 2020; 9 (12): 3926. https://doi.org/10.3390/jcm9123926Radmilovic J., Di Vilio A., D’Andrea A., Pastore F., Forni A., Desiderio A., Ragni M., Quar anta G., Cimmino G., Russo V., Scherillo M., Golino P. The Pharmacological Approach to Oncologic Patients with Acute Coronary Syndrome. J Clin Med. 2020; 9 (12): 3926. https://doi.org/10.3390/jcm9123926AlHawwas M., Tsitlakidou D., Gupta N., Iliescu C., Cilingiroglu M., Marmagkiolis K. Acute Coronary Syndrome Management in Cancer Patients. Curr Oncol Rep. 2018; 20 (10): 78. https://doi.org/10.1007/s11912–018–0724–8AlHawwas M., Tsitlakidou D., Gupta N., Iliescu C., Cilingiroglu M., Marmagkiolis K. Acute Coronary Syndrome Management in Cancer Patients. Curr Oncol Rep. 2018; 20 (10): 78. https://doi.org/10.1007/s11912–018–0724–8Rohrmann S., Witassek F., Erne P., Rickli H., Radovanovic D. Treatment of patients with myocardial infarction depends on history of cancer. Eur Heart J Acute Cardiovasc Care. 2018; 7 (7): 639–645. https://doi.org/10.1177/2048872617729636Rohrmann S., Witassek F., Erne P., Rickli H., Radovanovic D. Treatment of patients with myocardial infarction depends on history of cancer. Eur Heart J Acute Cardiovasc Care. 2018; 7 (7): 639–645. https://doi.org/10.1177/2048872617729636Collet J. P., Thiele H., Barbato E., Barthélémy O., Bauersachs J., Bhatt D. L., Dendale P., Dorobantu M., Edvardsen T., Folliguet T., Gale C. P., Gilard M., Jobs A., Jüni P., Lam brinou E., Lewis B. S., Mehilli J., Meliga E., Merkely B., Mueller C., Roffi M., Rutten F. H., Sibbing D., Siontis G. C.M.; ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without per sistent STsegment elevation. Rev Esp Cardiol (Engl Ed). 2021; 74 (6): 544. https://doi.org/10.1016/j.rec.2021.05.002Collet J. P., Thiele H., Barbato E., Barthélémy O., Bauersachs J., Bhatt D. L., Dendale P., Dorobantu M., Edvardsen T., Folliguet T., Gale C. P., Gilard M., Jobs A., Jüni P., Lam brinou E., Lewis B. S., Mehilli J., Meliga E., Merkely B., Mueller C., Roffi M., Rutten F. H., Sibbing D., Siontis G. C.M.; ESC Scientific Document Group. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without per sistent STsegment elevation. Rev Esp Cardiol (Engl Ed). 2021; 74 (6): 544. https://doi.org/10.1016/j.rec.2021.05.002Mohamed M. O., Van Spall H. G.C., Kontopantelis E., Alkhouli M., Barac A., Elgendy I. Y., Khan S. U., Kwok C. S., Shoaib A., Bhatt D. L. Effect of primary percutaneous coronary intervention on inhospital outcomes among active cancer patients presenting with STelevation myocardial infarction: A propensity score matching analysis. Eur. Heart J. Acute Cardiovasc. Care 2021; 10: 829–839.Mohamed M. O., Van Spall H. G.C., Kontopantelis E., Alkhouli M., Barac A., Elgendy I. Y., Khan S. U., Kwok C. S., Shoaib A., Bhatt D. L. Effect of primary percutaneous coronary intervention on inhospital outcomes among active cancer patients presenting with STelevation myocardial infarction: A propensity score matching analysis. Eur. Heart J. Acute Cardiovasc. Care 2021; 10: 829–839.Styczkiewicz K., Styczkiewicz M., Myćka M., Mędrek S., Kondraciuk T., CzerkiesBieleń A., Wiśniewski A., Szmit S., & Jankowski P. et al. Clinical presentation and treatment of acute coronary syndrome as well as 1year survival of patients hospitalized due to cancer: A 7year experience of a nonacademic center. Medicine (Baltimore). 2020; 99 (5): e18972. DOI: 10.1097/md.0000000000018972.Styczkiewicz K., Styczkiewicz M., Myćka M., Mędrek S., Kondraciuk T., CzerkiesBieleń A., Wiśniewski A., Szmit S., & Jankowski P. et al. Clinical presentation and treatment of acute coronary syndrome as well as 1year survival of patients hospitalized due to cancer: A 7year experience of a nonacademic center. Medicine (Baltimore). 2020; 99 (5): e18972. DOI: 10.1097/md.0000000000018972.Monlezun D. J., Lawless S., Palaskas N., Peerbhai S., Charitakis K., Marmagkiolis K., Lo pezMattei J., Mamas M., & Iliescu C. (2021). Machine LearningAugmented Propensity Score Analysis of Percutaneous Coronary Intervention in Over 30 million Cancer and Noncancer Patients. Frontiers in cardiovascular medicine 2021; 8: 620857. https://doi.org/10.3389/fcvm.2021.620857Monlezun D. J., Lawless S., Palaskas N., Peerbhai S., Charitakis K., Marmagkiolis K., Lo pezMattei J., Mamas M., & Iliescu C. (2021). Machine LearningAugmented Propensity Score Analysis of Percutaneous Coronary Intervention in Over 30 million Cancer and Noncancer Patients. Frontiers in cardiovascular medicine 2021; 8: 620857. https://doi.org/10.3389/fcvm.2021.620857Zamorano J. L., Lancellotti P., Rodriguez Muñoz D., Aboyans V., Asteggiano R., Galderisi M., Habib G., Lenihan D. J., Lip G. Y.H., Lyon A. R., Lopez Fernandez T., Mohty D., Piepo li M. F., Tamargo J., Torbicki A., Suter T. M., & ESC Scientific Document Group. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treat ments and cardiovascular toxicity of the European Society of Cardiology (ESC). Euro pean Heart Journal, 2016; 37 (36): 2768–2801. https://doi.org/10.1093/eurheartj/ehw211Zamorano J. L., Lancellotti P., Rodriguez Muñoz D., Aboyans V., Asteggiano R., Galderisi M., Habib G., Lenihan D. J., Lip G. Y.H., Lyon A. R., Lopez Fernandez T., Mohty D., Piepo li M. F., Tamargo J., Torbicki A., Suter T. M., & ESC Scientific Document Group. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treat ments and cardiovascular toxicity of the European Society of Cardiology (ESC). Euro pean Heart Journal, 2016; 37 (36): 2768–2801. https://doi.org/10.1093/eurheartj/ehw211Guddati A. K., Joy P. S., & Kumar G. (2016). Analysis of outcomes of percutaneous coronary intervention in metastatic cancer patients with acute coronary syndrome over a 10year period. Journal of Cancer Research and Clinical Oncology 2016; 142 (2): 471–479. https://doi.org/10.1007/s00432–015–2056–5Guddati A. K., Joy P. S., & Kumar G. (2016). Analysis of outcomes of percutaneous coronary intervention in metastatic cancer patients with acute coronary syndrome over a 10year period. Journal of Cancer Research and Clinical Oncology 2016; 142 (2): 471–479. https://doi.org/10.1007/s00432–015–2056–5Ueki Y., Vögeli B., Karagiannis A., Zanchin T., Zanchin C., Rhyner D., Otsuka T., Praz F., Siontis G. C.M., Moro C., Stortecky S., Billinger M., Valgimigli M., Pilgrim T., Windecker S., Suter T., & Räber L. Ischemia and Bleeding in Cancer Patients Undergoing Percutane ous Coronary Intervention. JACC. Cardio Oncology 2019; 1 (2), 145–155. https://doi.org/10.1016/j.jaccao.2019.11.001Ueki Y., Vögeli B., Karagiannis A., Zanchin T., Zanchin C., Rhyner D., Otsuka T., Praz F., Siontis G. C.M., Moro C., Stortecky S., Billinger M., Valgimigli M., Pilgrim T., Windecker S., Suter T., & Räber L. Ischemia and Bleeding in Cancer Patients Undergoing Percutane ous Coronary Intervention. JACC. Cardio Oncology 2019; 1 (2), 145–155. https://doi.org/10.1016/j.jaccao.2019.11.001Iliescu C., Grines C. L., Herrmann J., Yang E. H., Cilingiroglu M., Charitakis K., Hakeem A., Toutouzas K., Leesar M. A., & Marmagkiolis K. SCAI expert consensus statement: Evaluation, management, and special considerations of cardiooncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Intervencionista). Catheterization and cardiovascular interventions: Official Journal of the Society for Cardiac Angiography & Interventions 2016; 87 (5): 895–899. https://doi.org/10.1002/ccd.26375Iliescu C., Grines C. L., Herrmann J., Yang E. H., Cilingiroglu M., Charitakis K., Hakeem A., Toutouzas K., Leesar M. A., & Marmagkiolis K. SCAI expert consensus statement: Evaluation, management, and special considerations of cardiooncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Intervencionista). Catheterization and cardiovascular interventions: Official Journal of the Society for Cardiac Angiography & Interventions 2016; 87 (5): 895–899. https://doi.org/10.1002/ccd.26375Blann A.D., & Dunmore S. Arterial and venous thrombosis in cancer patients. Cardiology Research and Practice 2011; 394740. https://doi.org/10.4061/2011/394740Blann A.D., & Dunmore S. Arterial and venous thrombosis in cancer patients. Cardiology Research and Practice 2011; 394740. https://doi.org/10.4061/2011/394740Tabata N., Sueta D., Yamamoto E., Takashio S., Arima Y., Araki S., Yamanaga K., Ishii M., Sakamoto K., Kanazawa H., Fujisue K., Hanatani S., Soejima H., Hokimoto S., Izumiya Y., Kojima S., Yamabe H., Kaikita K., Tsujita K., & KUMA study investigators. Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) study. European heart journal. Quality of care & clinical outcomes 2018; 4 (4): 290–300. https://doi.org/10.1093/ehjqcco/qcx047Tabata N., Sueta D., Yamamoto E., Takashio S., Arima Y., Araki S., Yamanaga K., Ishii M., Sakamoto K., Kanazawa H., Fujisue K., Hanatani S., Soejima H., Hokimoto S., Izumiya Y., Kojima S., Yamabe H., Kaikita K., Tsujita K., & KUMA study investigators. Outcome of current and history of cancer on the risk of cardiovascular events following percutaneous coronary intervention: a Kumamoto University Malignancy and Atherosclerosis (KUMA) study. European heart journal. Quality of care & clinical outcomes 2018; 4 (4): 290–300. https://doi.org/10.1093/ehjqcco/qcx047McCarthy C. P., Steg G., Bhatt, D. L. The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: A clinical conundrum. European Heart Journal 2017; 38 (47): 3488–3492. https://doi.org/10.1093/eurheartj/ehx531McCarthy C. P., Steg G., Bhatt, D. L. The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: A clinical conundrum. European Heart Journal 2017; 38 (47): 3488–3492. https://doi.org/10.1093/eurheartj/ehx531Bharadwaj A. S., Swamy P. M., Mamas M. A. Outcomes of percutaneous coronary interventions in cancer patients. Expert Review of Cardiovascular Therapy 2020; 18 (1): 25–32. https://doi.org/10.1080/14779072.2020.1718493Bharadwaj A. S., Swamy P. M., Mamas M. A. Outcomes of percutaneous coronary interventions in cancer patients. Expert Review of Cardiovascular Therapy 2020; 18 (1): 25–32. https://doi.org/10.1080/14779072.2020.1718493Kwok C. S., Wong C. W., Kontopantelis E., Barac A., Brown S. A., Velagapudi P., Hil liard A. A., Bharadwaj A. S., Chadi Alraies M., Mohamed M., Bhatt D. L., Mamas M. A. (2021). Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA. European Heart Journal 2021; 42 (10): 1019–1034. https://doi.org/10.1093/eurheartj/ehaa1032Kwok C. S., Wong C. W., Kontopantelis E., Barac A., Brown S. A., Velagapudi P., Hil liard A. A., Bharadwaj A. S., Chadi Alraies M., Mohamed M., Bhatt D. L., Mamas M. A. (2021). Percutaneous coronary intervention in patients with cancer and readmissions within 90 days for acute myocardial infarction and bleeding in the USA. European Heart Journal 2021; 42 (10): 1019–1034. https://doi.org/10.1093/eurheartj/ehaa1032Potts J. E., Iliescu C. A., Lopez Mattei J. C., Martinez S. C., Holmvang L., Ludman P., De Belder M. A., Kwok C. S., Rashid M., Fischman D. L., Mamas M. A. Percutaneous coro nary intervention in cancer patients: A report of the prevalence and outcomes in the United States. European Heart Journal 2019; 40 (22): 1790–1800. https://doi.org/10.1093/ eurheartj/ehy769Potts J. E., Iliescu C. A., Lopez Mattei J. C., Martinez S. C., Holmvang L., Ludman P., De Belder M. A., Kwok C. S., Rashid M., Fischman D. L., Mamas M. A. Percutaneous coro nary intervention in cancer patients: A report of the prevalence and outcomes in the United States. European Heart Journal 2019; 40 (22): 1790–1800. https://doi.org/10.1093/ eurheartj/ehy769Borovac J. A., Kwok C. S., Iliescu C., Lee H. J., Kim P. Y., Palaskas N. L., Zaman A., Butler R., LopezMattei J.C., Mamas M. A. Percutaneous Coronary Intervention and Outcomes in Patients with Lymphoma in the United States (Nationwide Inpatient Sample [NIS] Analysis). The American Journal of Cardiology 2019; 124 (8): 1190–1197. https://doi.org/10.1016/j.amjcard.2019.07.015Borovac J. A., Kwok C. S., Iliescu C., Lee H. J., Kim P. Y., Palaskas N. L., Zaman A., Butler R., LopezMattei J.C., Mamas M. A. Percutaneous Coronary Intervention and Outcomes in Patients with Lymphoma in the United States (Nationwide Inpatient Sample [NIS] Analysis). The American Journal of Cardiology 2019; 124 (8): 1190–1197. https://doi.org/10.1016/j.amjcard.2019.07.015Sarkiss M. G., Yusuf S. W., Warneke C. L., BotzG., Lakkis N., HirchGinsburg C., Champi on J. C., Swafford J., Shaw A. D.S., Lenihan D. J. Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer 2006; 109: 621–627.Sarkiss M. G., Yusuf S. W., Warneke C. L., BotzG., Lakkis N., HirchGinsburg C., Champi on J. C., Swafford J., Shaw A. D.S., Lenihan D. J. Impact of aspirin therapy in cancer patients with thrombocytopenia and acute coronary syndromes. Cancer 2006; 109: 621–627.Iliescu C., Grines C. L., Herrmann J., Yang E. H., Cilingiroglu M., Charitakis K., Hakeem A., Toutouzas K., Leesar, M. A., Marmagkiolis, K. SCAI expert consensus statement: Evaluation, management, and special considerations of cardiooncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Intervencionista). Catheterization and cardiovascular interventions: Official Journal of the Society for Cardiac Angiography & Interventions 2016; 87 (5): 895–899. https://doi.org/10.1002/ccd.26375Iliescu C., Grines C. L., Herrmann J., Yang E. H., Cilingiroglu M., Charitakis K., Hakeem A., Toutouzas K., Leesar, M. A., Marmagkiolis, K. SCAI expert consensus statement: Evaluation, management, and special considerations of cardiooncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Intervencionista). Catheterization and cardiovascular interventions: Official Journal of the Society for Cardiac Angiography & Interventions 2016; 87 (5): 895–899. https://doi.org/10.1002/ccd.26375

The authors declare that there are no conflicts of interest present.